Three-dimensional (3D) speckle tracking echocardiography (3DSTE) offers clinicians a new noninvasive tool in characterizing and understanding preclinical cardiac involvement via 3D strain analysis, which is unique to this tool. 6 3DSTE is a validated method for left atrial (LA) quantification as compared to two-dimensional (2D) echocardiography, 2DSTE, and volumetric real-time 3D echocardiography (RT3DE). [6] [7] [8] The number of studies concerning acromegaly-associated LA volumetric and functional changes is limited. 9 The objective of this study was to investigate 3DSTE-derived LA volumetric and functional properties in patients with acromegaly. It was also examined whether the activity of acromegaly is associated with further alterations in these LA parameters.
| ME THODS

| Patientpopulation
A total of 23 patients with acromegaly were involved in this study. Due to inadequate image quality, 4 patients were excluded from the 3DSTE
analysis. The mean age of the remaining acromegalic subjects was 58.5 ± 13.1 years, from which 7 subjects were male. Acromegaly was diagnosed according to relevant clinical standards: typical clinical features and elevated serum GH and/or IGF-1 levels not suppressible with oral glucose tolerant test (OGTT, 75 g). 5 The acromegaly patient group was further divided into two subgroups based on the activity of the disease. Patients were allocated to the active subgroup if serum GH levels F I G U R E 1 Three-dimensional (3D) speckle tracking echocardiographic assessment of the left atrium (LA) is displayed in an acromegaly patient. Apical four-chamber view (A), apical two-chamber view (B), short-axis view at basal (C3), midatrial (C5), and superior left atrial level (C7) are presented together with a 3D model of the LA and calculated volumetric data. Time-LA global volume (dashed line) and Time-LA circumferential segmental strain curves (colorized lines). EDV = end-diastolic volume; ESV = end-systolic volume; EF = ejection fraction; LA = left atrium were above the standard threshold. 5, 10 Control group consisted of 21 age-and gender-matched healthy subjects (mean age 51.8 ± 10.3 years, 10 male). All data of acromegalic patients were taken from the MAGYAR-Path Study (Motion Analysis of the heart and Great vessels bY three-dimensionAl speckle-tRacking echocardiography in Pathological cases), which was created to assess diagnostic and prognostic value of 3DSTE-derived parameters ("magyar" means "Hungarian" in Hungarian language). The study complied with the Declaration of Helsinki and was approved by the institutional human research committee. All patients and control subjects gave informed consent.
| Two-dimensionalDopplerandtissueDoppler echocardiography
All acromegalic patients and negative control subjects underwent a complete two-dimensional (2D) transthoracic echocardiographic assessment using a Toshiba Artida imaging system (Toshiba Medical Systems, Tokyo, Japan) with a PST-30SBP (1-5 MHz)
phased array transducer. According to routine clinical standards, complete 2D Doppler study was performed in all cases including quantification of LV dimensions, volumes, ejection fraction, and LA dimensions. 
| Three-dimensionalspeckletracking echocardiography
Three-dimensional speckle tracking echocardiography measurements were performed using the same Toshiba Artida echocardiography equipment with a PST-25SX matrix-array transducer with 3DSTE capability.
Full-volume 3D datasets were obtained by combining 6 R-wave triggered wedge-shaped subvolumes during 6 cardiac cycles. Subvolumes were registered during a single breath-hold and constant RR interval from the apical window. TA B L E 1 Demographic, clinical, and two-dimensional echocardiographic data of patients with acromegaly and controls views of the LA at end-diastole automatically. After image optimization, the reader detected the endocardial border by placing 6-8 markers to the edge of the septum-mitral annulus (MA) toward the edge of the lateral wall-MA (Figures 1 and 2) . Then, the software automatically reconstructed the endocardial surface of the LA and performed volumetric and strain analyses. The frame rate changed between 27 and 30/s, and volume rates were between 27 and 30 vps during 3DSTE assessments.
| 3DSTE-derivedLAvolumetricmeasurements
The following volumetric data were obtained from the 3DSTE datasets ( Figure 1 ):
• End-systolic maximum LA volume (V max, before mitral valve opening).
• Early diastolic LA volume before atrial contraction (V PreA , at the time of the P-wave on the ECG).
• End-diastolic minimum LA volume (V min , before mitral valve closure).
Based on the acquired volumetric data, several functional parameters were calculated representing systolic reservoir and diastolic conduit and active contraction LA functional phases. 
| 3DSTE-derivedLAstrainassessments
Using the same 3D datasets, the software obtained several lin- AAEF (%) 32.5 ± 10.4 31.9 ± 9.4 28.0 ± 9.7** 37.5 ± 6.0 AASV = active atrial stroke volume; AAEF = active atrial emptying fraction; BSA = body surface area; PAEF = passive atrial emptying fraction; PASV = passive atrial stroke volume; TAEF = total atrial emptying fraction; TASV = total atrial stroke volume; V max = maximum left atrial volume; V min = minimum left atrial volume; V preA = left atrial volume before atrial contraction. *P < .05 vs controls. **P < .05 vs inactive acromegaly.
in systole, while strains at atrial contraction were obtained at end-diastole (LA systole) to characterize LA booster pump function ( Figure 1 
| RE SULTS
| Demographicdataofpatientswithacromegaly
Demographic and clinical data are presented in Table 1 
| Two-dimensionalechocardiographicdata
Out of 2D echocardiography parameters, LA diameter, body surface area (BSA)-indexed LA diameter, and LV posterior wall thickness were significantly different between the patient populations (P < .0001, P = .005, P = .02, respectively). Early filling transmitral flow velocity (E) was not significantly different; however, late filling transmitral flow velocity (A) and E/A ratio differed significantly between controls and acromegaly patients (P = .01 and P = .002, respectively). Among all acromegaly patients, mild-to-moderate mitral regurgitation was present in 7 cases (Table 1 ).
| 3DSTE-derivedvolumesandvolume-basedLA functionalproperties
All three LA volumetric parameters (V max , V preA , V min ) were significantly different between all acromegaly patients (P ≤ .0001, P ≤ .0001, P ≤ .0001, respectively), active (P = .004, P = .004, P ≤ .0001, respectively), and inactive acromegaly patients (P ≤ .0001, P ≤ .0001, P = .0001, respectively) compared with negative controls. Similarly, all BSA-indexed V max , V preA , and V min were significantly different between all acromegaly patients (P = .0003, P = .0003, P = .0004, respectively), active (P = .03, P = .008, P = .0004, respectively), and inactive acromegaly patients (P = .0003, P = .002, P = .0006, respectively). Out of LA volumebased functional properties, only total and active SVs differed significantly between all acromegaly patients and healthy controls (P = .0003, P = .0002, respectively). BSA-indexed total and active SVs showed similar differences (P = .003, P = .006, respectively).
Only total SV was significantly increased in active acromegaly patients as compared to that of the control group (P = .03). Significant differences could be demonstrated between inactive acromegaly patients and control patients regarding all three stroke volumes (total, passive, and active SVs) (P < .0001, P = .03, P < .0001, respectively). From BSA-indexed parameters, total and active SVs differed significantly (P = .0006, P = .0004, respectively). Between the active and inactive acromegaly patient subgroups, only active EF differed significantly (P = .03) ( Table 2 ). There was no significant correlation between volumetric parameters and mean GH, IGF-1, or IGF-1 index.
| 3DSTE-derivedpeakLAstrainparameters
Increased global and mean segmental peak RS (P = .04, P = .02) and 3DS (P = .02, P = .02) and decreased global and mean segmental CS (P = .02, P = .04) could be detected in all acromegaly patient groups as compared to the group of healthy subjects (Table 3, Figure 3 ).
Global and mean segmental peak CS (P = .02, P = .05) and mean segmental AS (P = .05) were found to be diminished, while mean segmental 3DS were increased (P = .05) in active acromegaly patients as compared to controls. Significantly increased mean segmental 3DS were found in data of the inactive acromegaly subgroup compared with healthy subjects (P = .03) ( Table 3 ). Regional differences in all peak strains between all acromegaly patients, active and inactive acromegaly patients, and controls are demonstrated in Table 3 .
Significant correlation could be detected in the acromegaly group F I G U R E 2 Three-dimensional (3D) speckle tracking echocardiographic assessment of all types of (segmental) strains (colored lines) and left atrial volume change (dashed white line) over cardiac cycle in a control subject and in active and inactive acromegalics between IGF-1 index and superior peak CS (r = .49, P = .05). In the active acromegaly subgroup, significant correlations were found between the basal peak CS and serum IGF-1 and IGF-1 index levels (r = .76, P = .007; r = .69, P = .02) (Figure 4 ).
| 3DSTE-derivedLAstrainsatatrialcontraction
Increased global and mean segmental 3DS (P = .02, P = .02, respectively) and mean segmental RS and LS (P = .03, P = .02, respectively) could be detected in all acromegaly patients compared with controls. While inactive acromegaly patients had the same global and mean segmental LA strain parameters as compared to that of controls, activity of acromegaly was associated with increased global and mean segmental RS (P = .01, P = .007) and 3DS (P = .02, P = .03). Moreover, significant differences could be detected between global and mean segmental RS (P = .01, P = .03) and mean segmental 3DS (P = .05) of active and inactive acromegaly patients (Table 4 , Figure 3 ). Regional differences in all strains at atrial contraction between all acromegaly patients, active and inactive acromegaly patients, and controls are demonstrated in Table 4 .
| D ISCUSS I ON
Acromegaly is a rare, chronic, progressive, and insidious disorder characterized by excess secretion of GH and elevated circulating levels of IGF-I, generally caused by a pituitary adenoma. 12 Acromegaly patients often have established systemic complications at diagnosis with increased morbidity and mortality mostly due to cardiovascular reasons. 13 The pathophysiology underlying cardiac involvement in acromegaly is not clearly understood, elevated GH serum levels and consequent plasma volume expansion and direct anti-natriuretic effect, increased peripheral vascular resistance may be the cause. LVH and myocardial fibrosis are considered common findings in acromegalic cardiomyopathy in echocardiography studies. 14 However, there is limited information on LA function in acromegaly. 9 Newer echocardiographic modalities including 3D and/or STE enable detailed assessment of not only the LV, but atrial functions as well. 8 3DSTE uses a "block-matching" by strain analysis algorithm to accurately assess volumetric and functional properties of the LA during different cardiac cycles. 8 Volumetric RT3DE is widely regarded as a highly accurate noninvasive method for volumetric
TA B L E 4
Comparison of 3DSTE-derived regional left atrial strain parameters at atrial contraction between patients with acromegaly and controls AS basal (%) 20. In a recent study, LA volumes (maximum, minimum, and presystolic) and LA mechanical functions were not significantly different in patients with active acromegaly compared with age-and gendermatched healthy controls. Additionally, serum levels of GH and IGF-1 did not correlate with LA mechanical functions. 9 A previous animal study examined 11 cats with acromegaly; 6 of the subject animals had significantly enlarged LA. 17 In a previous study presenting 3 acromegalic patients with heart failure, the LA was found to be enlarged in all three cases. 18 To the best of the author's knowledge, be the most sensitive parameter, and the above-described changes might suggest a somewhat reversible atrial dysfunction after proper treatment of acromegaly.
The above-described LA changes may be reactive to the LV changes that are characteristic in acromegaly. In the early stages, hyperkinetic syndrome and LVH are the primary changes (caused by increased Ca-sensitivity thus increased myocardial contractility); as the disease progresses, LVH becomes more prominent and diastolic ventricular filling becomes impaired. In the later stages, extracellular collagen deposition and thus reduced systolic and diastolic function, LV remodeling, and heart failure characterize the clinical picture. [19] [20] [21] [22] The remodeling of the LA might also occur, parallel to the LVH, but the possible effect of collagen deposition cannot be ruled out either. The real mechanism behind the LA volumetric and functional alterations and LA remodeling is not known yet in acromegaly.
The increased LA volumes and augmented SVs might be due to the decreased diastolic filling of the LV; however, the effect of hypertension and a certain degree of mitral regurgitation cannot be ruled out as these are common findings in acromegaly. Moreover, agerelated changes could have an effect, as well. The hormonal changes (GH and IGF-1) might also play a notable part in the remodelation of the LA.
| Limitations
The main limitation of this study is the low number of acromegaly patients involved. In the present study, we did not take into account for how long the acromegaly was active after the diagnosis, or for how long the disease was inactive in case of successful treatment.
The possible effects of the specific drugs used in the treatment of acromegaly on LA volumetric, functional, and strain parameters
were not explored in this study. In addition, the spatial resolution of 3DSTE is relatively poor compared to that of 2D echocardiography.
There are no reference values for 3DSTE-derived LA strain, volumetric and functional parameters at this time; therefore, LA data of control patients might differ compared to other studies. Due to the nature of the software used, only R-wave triggered measurements were possible; even though in case of LA, P-wave triggering is superior. 23 The software is capable of measuring RS, but in case of the atria, it is thought to be a weak parameter due to the thinness of atrial walls. Even though 3DSTE is a feasible imaging modality for quantifying LA volumetric and strain assessments, further validation studies with larger populations are warranted.
| CON CLUS ION
Acromegaly is associated with increased LA volumes and changes in LA functional properties.
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